AzurRx BioPharma, Inc.
AzurRx BioPharma, Inc. (AZRX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
azrx · stock forecast · 4 analysts (3M) · FMP · updated Mar 14, 2024
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $3.45
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $3.28 | ↓ 5.00% |
1-day model range: $3.21–$3.35. Peak: $3.35 (-5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AZRX · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2021-08-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2021-04-01 | Roth Capital | Maintains | Buy→Buy |
| 2021-04-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2021-02-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2020-04-01 | H.C. Wainwright | Maintains | Buy→Buy |
| 2019-09-26 | H.C. Wainwright | Maintains | Buy→Buy |
| 2019-04-18 | H.C. Wainwright | Maintains | Buy→Buy |
| 2019-02-14 | Maxim Group | Maintains | Buy→Buy |
| 2019-01-25 | Roth Capital | Maintains | Buy→Buy |
| 2017-07-24 | H.C. Wainwright | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on AzurRx BioPharma, Inc. (AZRX) stock. Of the recent 10 rating actions, 0 were upgrades and 0 were downgrades. 4 analysts currently cover AZRX.
Analyst Recommendation Trends
AZRX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
—
Revenue Next Year
—
EPS This Year
—
EPS Next Year
—
EPS ForecastReported vs Estimated
Analysts forecast AZRX EPS of $— for the current fiscal year, based on estimates from 0 analysts. The AZRX revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The AZRX stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AZRX price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The AZRX short-term stock prediction for tomorrow is $3.28 (-5.00%).
AzurRx BioPharma, Inc. trades on NASDAQ under the ticker AZRX. The AZRX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
AZRX forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month AZRX price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $3.45.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.